NCT01560234View on ClinicalTrials.gov

AZD8848 Single Ascending Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Healthy

Interventions

DRUG

AZD8848

Single dose, oral inhalation (nebuliser solution)

DRUG

Placebo

Single dose, oral inhalation (nebuliser solution)

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY